Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT(1B) agonist into the dorsal subiculum: Implications for schizophrenia

Journal of Psychopharmacology

Volumn 12, Issue 3, 1998, Pages 258-267

  Boulenguez, P ^a,c   Peters, S L ^a   Mitchell, S N ^a,d   Chauveau, J ^b   Gray, J A ^a   Joseph, M H ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Immunotech   (France)

^c INSERM   (France)

^d ELI LILLY AND COMPANY   (United States)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Attention; Dopamine; Glutamate NMDA and Q K receptors hippocampal formation; Microdialysis; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DIHYDROXYPHENYLACETIC ACID; DIZOCILPINE; HOMOVANILLIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN 1B AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRACELLULAR FLUID; LATENT INHIBITION; MALE; MICRODIALYSIS; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031737159     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200305     Document Type: Article

References (73)

1. 2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16: 517-525
2. Anscombe F (1987) The disorder of consciousness in schizophrenia. Schizophr Bull 13: 241-260
3. Baruch I, Hemsley D R, Gray J A (1988) Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 176: 598-606
4. Bleich A, Brow S-L, Kahn R, van Praag H M (1988) The role of serotonin in schizophrenia. Schizophr Bull 14: 287-315
5. Bogerts B (1990) The neuropathology of schizophrenia. In Häfner H, Gattaz W F (eds), Search for the cause of schizophrenia, Vol II. Springer Verlag, Berlin, Heidelberg, pp. 229-241
6. 1B receptor is localized predominantly on axon terminals. Neuroscience 58: 167-182
7. 1D binding sites. J Pharmac Exp Ther 259: 1360-1365
8. 1D binding sites. J Neurochem 58: 951-959
9. 1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology 35: 1521-1529
10. Brazell M P, Mitchell S N, Joseph M H, Gray J A (1990) Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29: 1177-1185
11. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33: 367-386
12. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179-203
13. Cassaday H J, Hodges H, Gray J A (1993) The effect of ritanserin, RU 24 969 and 8-OH-DPAT on latent inhibition in the rat. J Psychopharmac 7: 63-71
14. Crespi F, Garrat J C, Sleight A J, Marsden C A (1990) In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience 35: 139-144
15. Cumming P, Brown E, Damsma G, Fibiger H (1992) Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. J Neurochem 59: 1905-1914
16. Deakin J F W, Slater P, Simpson M D C, Gilchrist A C, Skan W J, Royston M C, Reynolds G P, Cross A J (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52: 1781-1786
17. Di Chiara G, Tanda G, Frau R, Carboni E (1993) On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology 112: 398-402
18. Dunn L A, Atwater G E, Kilts C D (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioural model of clinical drug action. Psychopharmacology 112: 315-323
19. Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rat's ability to ignore irrelevant stimuli. Biol Psychiat 29: 635-646
20. Feldon J, Weiner I (1992) From an animal model of an attentional deficit toward new insights into the pathophysiology of schizophrenia. J Psychiat Res 26: 345-366
21. Feldon J, Shofel A, Weiner I (1991) Latent inhibition is unaffected by direct dopamine agonists. Pharmac Biochem Behav 38: 309-314
22. Fuller T A, Russchen F T, Price J L (1987) Source of presumptive glutamatergic/aspartatergic afferents to the rat ventral striatopallidal region. J Comp Neurol 258: 317-338
23. Glennon R A (1990) Serotonin receptors: clinical implications. Neurosci Behav Rev 14: 35-47
24. Gray J A, Feldon J, Rawlins J N P, Hemsley D R, Smith A D (1991) The neuropsychology of schizophrenia. Behav Brain Sci 14: 1-84
25. Gray J A, Joseph M H, Hemsley D R, Young A M J, Warburton E C, Boulenguez P, Grigoryan G A, Peters S L, Rawlins J N P, Tai C-T, Yee B K, Cassaday H, Weiner I, Gal G, Gusak O, Joel D, Shadrach E, Shalev U, Tarrasch R, Feldon J (1995) The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res 71: 19-31
26. Gray N S, Hemsley D R, Gray J A (1992a) Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiat Br Res 1: 83-89
27. Gray N S, Pickering A D, Hemsley D R, Dawling S, Gray J A (1992b) Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology 107: 425-430
28. Gray N S, Pilowsky L S, Gray J A, Kerwin R W (1995) Latent inhibition in drug-naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res 17: 95-107
29. Groenewegen H J, Vermeulen-Van Der Zee E, Te Kortschot A, Witter M P (1987) Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin. Neuroscience 23: 103-120
30. Harrison P J, McLaughlin D, Kerwin R W (1991) Decreased hippocampal expression of a glutamate receptor gene in schizophrenics. Lancet 337: 450-452
31. Hemsley D R (1987) An experimental psychological model for schizophrenia. In Hafner H, Gattaz W F, Janzavik W (eds), Search for the causes of schizophrenia. Springer, Stuttgart
32. Hemsley D R (1993) A simple (or simplistic?) cognitive model for schizophrenia. Behav Res Ther 31: 633-645
33. Hemsley D R (1994) Cognitive disturbance as the link between schizophrenic symptoms and their biological bases. Neurol Psychiat Brain Res 2: 163-170
34. Imperato A, Honoré T, Jensen L H (1990a) Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely moving rats. Brain Res 530: 223-228
35. Imperato A, Scrocco M G, Bacchi S, Angelucci L (1990b) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmac 187: 555-556
36. Joseph M H, Peters S L, Gray J A (1993) Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology 110: 187-192
37. Kaye H, Pearce J M (1987) Hippocampal lesions attenuate latent inhibition of a CS and of a neutral stimulus. Psychobiology 15: 293-299
38. Keefe K A, Zigmond M J, Abercrombie E D (1993) In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J Neural Transm [Gen Sect] 91: 223-240
39. Kerwin R W (1993) Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. Psychol Med 23: 547-551
40. Kerwin R W, Collier D (1996) The dopamine D-4 receptor in schizophrenia: an update. Psychol Med 26: 221-227
41. Killcross A S, Robbins T W (1993) Differential effects of intraaccumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology 115: 185-195
42. Leviel V, Gobert A, Guibert B (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39: 305-312
43. Löscher W, Annies R, Hönack D (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci Letts 128: 191-194
44. Lubow R E, Moore A U (1959) Latent inhibition: the effect of non-reinforced pre-exposure to the conditioned stimulus. J Comp Physiol Psychol 52: 415-419
45. Meltzer H Y (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99: S18-S27
46. Meltzer H Y (1991) Dopaminergic and serotoninergic mechanisms in the action of clozapine. In Tammings C A, Schultz S C (eds), Advances in neuropsychiatry and psychopharmacology, Vol. 1. Schizophrenia research. Raven Press, New York
47. Meredith G E, Wouterlood F G, Pattiselanno A (1990) Hippocampal fibers make synaptic contacts with glutamate decarboxylase-immunoreactive neurons in the rat nucleus accumbens. Brain Res 513: 329-334
48. Moghaddam B, Bolinao M L (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 18: 337-342
49. Noga J T, Hyde T M, Herman M, Bigelow L L, Weinberger D R, Kleinman J E (1994) Glutamate receptor autoradiography of postmortem basal ganglia in schizophrenia. Biol Psychiat Abstr 35: 311-325
50. 1 agonist RU 24 969 and effects on dopaminergic behaviour. Eur J Pharmac 139: 205-214
51. Paxinos G, Watson C (1987) The rat brain in stereotaxic coordinates. Academic Press, Sydney
52. Peters S L, Joseph M H (1993) Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure. Behav Pharmac 4: 183-186
53. Robinson T E, Becker J B (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
54. Schmajuk N A, Lam Y-W, Christiansen B A (1994) Latent inhibition of the rat eyeblink response: effect of hippocampal aspiration lesions. Physiol Behav 55: 597-601
55. Sesack S R, Pickel V M (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527: 266-279
56. Soares-da-Silva P (1987) Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release? J Pharm Pharmac 39: 127-129
57. Soares-da-Silva P (1990) A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC. Neuropharmacology 29: 869-874
58. Solomon P R, Staton D M (1982) Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate-putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiat 17: 742-756
59. Strassman R J (1992) Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology 7: 241-243
60. Tarrasch R, Weiner I, Rawlins J N P, Feldon J (1992) Disruption of latent inhibition by interrupting the subicular input to the nucleus accumbens and its antagonism by haloperidol. J Psychopharmac 6: 111
61. Ulas J, Cotman C W (1993) Excitatory amino acid receptors in schizophrenia. Schizophr Bull 19: 105-117
62. Van Praag H M (1992) Serotonergic mechanisms in the pathogenesis of schizophrenia. In Lindenmayer J P, Kay S R (eds), New biological vistas on schizophrenia. Brunner/Mazel, New York, pp. 182-206
63. Wan F J, Geyer M A, Swerdlow N R (1995) Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology 120: 433-441
64. Warburton E C, Mitchell, S N, Joseph M H (1996) Calcium dependent dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition. Behav Pharmac 7: 119-129
65. Weiner I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108: 442-461
66. Weiner I, Lubow R E, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmac Biochem Behav 30: 871-878
67. Wheeler D, Boutelle M G, Fillenz M (1995) The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65: 767-774
68. Woolley D W, Shaw E (1954) A biochemical and pharmacological suggestion about certain mental disorder. Proc Natl Acad Sci 40: 228-231
69. Wu M, Brudzynski S M, Mogenson G J (1993) Functional interaction of dopamine and glutamate in the nucleus accumbens in the regulation of locomotion. Can J Physiol Pharmac 71: 407-413
70. Yoshida M, Yokoo H, Tanaka T, Mizoguchi K, Emoto H, Ishii H, Tanaka M (1993) Facilitatory modulation of mesolimbic dopamine neuronal activity by a m-opioid agonist and nicotine as examined with in vivo microdialysis. Brain Res 624: 277-280
71. Young A M J, Joseph M H, Gray J A, (1993) Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience 54: 5-9
72. Youngren K D, Daly D A, Moghaddam B (1993) Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J Pharmac Exp Ther 264: 289-293
73. Zetterström T, Sharp T, Collin A K, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmac 148: 327-334